Skip to main content


Log in

Cannabinoids and Sleep: Helpful or Harmful?

  • Sleeping and Breathing (A Abreu, Section Editor)
  • Published:
Current Pulmonology Reports Aims and scope Submit manuscript


Purpose of Review

Legalization and popular use of cannabis products have historically outpaced scientific literature. There is interest in the effects of cannabis and cannabinoids on human sleep and sleep disorders. This review summarizes research evaluating the relationship between cannabinoids and sleep published after 2016 and references background studies for clarification where no recent publications were available.

Recent Findings

Specific to sleep disorders, the most impactful research is arguably in the treatment of sleep disordered breathing though case reports are emerging to address several other conditions such as anxiety-mediated insomnia and restless legs syndrome.


Due to limitations including the Schedule I drug designation of cannabis and the heterogeneity of compounds in the cannabinoid family, current published works are likely insufficient to serve as a basis for clinical recommendations regarding the use of cannabinoids in sleep medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others


Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. National Conference of State Legislatures. State Medical Marijuana Laws. 2019 [Updated 2019 Oct 16, cited 2019 Dec 21]. Available from:

  2. National Academies of Sciences, Engineering and Medicine; Health and Medicine Division’ Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington (DC): National Academies Press (US); 2017 Jan 12. 3. Available from This publication provides a detailed overview of the current status of cannabis research in the field of health.

  3. Azofeifa A, Mattson ME, Schauer G, McAfee T, Grant A, Lyerla R. National estimates of marijuana use and related indicators-National Survey on Drug Use and Health, United States, 2002–2014. Morbidity and Mortality Weekly Report. 65(SS-11):1–25.

  4. Corroon J, Phillips JA. A cross-sectional study of cannabidiol users. Cannabis Cannabinoid Res. 2018;3(1):152–61.

    Article  CAS  Google Scholar 

  5. Boehnke KF, Gangopadhyay S, Clauw DJ, Haffajee R. Qualifying conditions of medical cannabis license holders in the United States. Health Aff (Milwood). 2019;38(3):511.

    Google Scholar 

  6. Carlini BH, Garrett SB, Carter GT. Medicinal cannabis: a survey among health care providers in Washington State. Am J Hosp Palliat Care. 2017;34(1):85–91.

    Article  Google Scholar 

  7. Brand EJ, Zhao Z. Cannabis in Chinese medicine: are some traditional indications referenced in ancient literature related to cannabinoids? Front Pharmacol. 2017;8:108.

    Article  Google Scholar 

  8. Schwabe AL, McGlaughlin ME. Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research. bioRxiv 332320; dos:

  9. Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev of Pharmacol Toxicol. 2006;46:101–22.

    Article  CAS  Google Scholar 

  10. Samson MT, Small-Howard A, Shimoda LMN, Koblan-Huberson M, Stokes AJ, Turner H. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol. 2003;170(10):4953–62.

    Article  CAS  PubMed  Google Scholar 

  11. Baboon KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Curt Psychiatry Rep. 2017;19:23.

    Article  Google Scholar 

  12. Gorelick DA, Goodwin RS, Schwilke E, Schroeder JR, Schwope DM, Kelly DL, et al. Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers. Am J Addict. 2013;5:510–4.

    Article  Google Scholar 

  13. Linares IM, Guimaraes FS, Eckeli A, Cripps ACS, Zuardi AW, Souza JDS, et al. No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized double-blind, placebo-controlled, crossover study. Front Pharmacol. 2018;9:315.

    Article  Google Scholar 

  14. Flores A, Maldonado R, Berrendero F. Cannabinoid-hypocretin crosstalk in the central nervous system: what we know so far. Front Neurosci. 2013;7:256.

    Article  Google Scholar 

  15. Flores A, Julia-Hernandez M, Maldonado R, Berrendero F. Involvement of the orexin/hypocretin system in the pharmacological effects induced by △9-tetrahydrocannabinol. Br J Pharmacol. 2016;173(8):1381–92.

    Article  CAS  Google Scholar 

  16. American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.

    Google Scholar 

  17. Vigil JM, Stith SS, Deviant JP, Brockelman F, Keeling K, Hall B. Effectiveness of raw, natural medical Cannabis flower for treating insomnia under naturalistic conditions. Medicines. 2018;11:5(3).

    Google Scholar 

  18. Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in anxiety and sleep: a large case series. Perm J. 2019 Jan;23:18–041.

    PubMed  PubMed Central  Google Scholar 

  19. Zinchuk A, Gentry M, Concato J, Yaggi K. Phenotypes in obstructive sleep apnea: a definition, examples and evolution of approaches. Sleep Med Rev. 2017;35:113–23 This publication describes the differences between phenotypic presentations of sleep apnea and provides the basis for a pharmaceutical approach in select groups of patients.

  20. Carley DW, Prasad B, Reid KJ, Malkani R, Attarian H, Abbott SM, et al. Pharmacotherapy of apnea by cannabimimetic enhancement, the PACE clinical trial: effects of dronabinol in obstructive sleep apnea. Sleep. 2018;41(1):zsx184. study represents one of the first clinical trials using pharmaceuticals to control obstructive sleep apnea.

  21. Prasad B, Radulovacki MG, Carley DW. Proof of concept trial of dronabinol in obstructive sleep apnea. Front Psychiatry. 2013;4:1.

    PubMed  PubMed Central  Google Scholar 

  22. Ramar K, Rosen IM, Kirsch DB, Chervin RD, Carden KA, Aurora RN, et al. American Academy of Sleep Medicine Board of Directors. Medical cannabis and the treatment of obstructive sleep apnea: an American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2018;14(4):679–81.

    Article  Google Scholar 

  23. Megelin T, Ghorayeb I. Cannabis for restless legs syndrome: a report of six patients. Sleep Med. 2017;36:182–3.

    Article  Google Scholar 

  24. Keith DR, Gunderson EW, Haney M, Foltin RW, Hart CL. Smoked marijuana attenuates performance and mood disruptions during simulated night shift work. Drug Alcohol Depend. 2017;178:534–43.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations



All authors participated in drafting and/or revising the manuscript for intellectual content and edited the manuscript for final approval.

Corresponding author

Correspondence to Aleksandra Kwasnik.

Ethics declarations

Conflict of Interest

The authors declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Sleeping and Breathing

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kwasnik, A., Abreu, A. & Chediak, A. Cannabinoids and Sleep: Helpful or Harmful?. Curr Pulmonol Rep 9, 96–101 (2020).

Download citation

  • Published:

  • Issue Date:

  • DOI: